Nitches Returns to Nutraceuticals, Opens Manufacturing Platform to Founders
NICH has more than doubled off its 52-week low of $0.
Summary
Nitches, Inc. is strategically refocusing its operations on the nutraceutical market, offering its integrated manufacturing and intelligence platform to external founders. This new business model provides end-to-end support for supplement brands, covering formulation, compliance, manufacturing, and distribution. For a company of this size, this pivot into a service-based model within a growing market represents a material shift in its revenue strategy. Further details on the intelligence platform are expected in the coming weeks.
At the time of this announcement, NICH was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $1.3M. The 52-week trading range was $0.00 to $66.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.